Zytronic (LON:ZYT) share price has been under selling pressure as one of its institutional investors sold down their holding. The recent share movements would indicate that the selling pressure has been removed. Does this mean that Zytronic (LON:ZYT) share price could rebound? They have plenty of cash in the bank to weather out Covid and stockopedia predicts a 10% div payment when they resume.
If trading reverts to some normalisation, it's worth noting:
- market cap is c£20m,
- v strong balance sheet - last year end: cash £13m, working capital: £18.6m and net assets £26m (incl freehold at £3.3m),
- dividends paid in last three years amounted to 65p a share.
Risk/reward looks very favourable for the patient.
